T h e r e c e n t r e p o r t i n N a t u r e Communica?ons se@les a persistent controversy in biology of aging research; namely, whether or not caloric restric?on (CR), reduced calorie intake without malnutri?on, confers health and longevity benefits in nonhuman primates. The University of Wisconsin-Madison and the Na?onal Ins?tute on Aging (NIA) at NIH study teams came together to analyze data from the two parallel studies that up un?l now had reported contras?ng outcomes of CR. In 2009, the UW-Madison study team reported significant benefits in survival and reduc?ons in cancer, cardiovascular disease, and insulin resistance for monkeys who ate less than their peers. In 2012, however, the NIA study team reported no significant improvement in survival, but did find a trend toward improved health. Working together, the compe?ng laboratories analyzed data gathered over many years from almost 200 monkeys from both studies. The authors concluded that lower calorie intake in adulthood and later in life confers benefits in terms of both health and survival in primates. A major outcome of these analyses was the beneficial effects of CR on health and disease incidence that was detected for both studies. One of the caveats specific to primate species was that star?ng on the diet too early in life may not be beneficial for longevity, unlike rodents where the earlier the animals go on the diet the longer the resul?ng lifespan.
The CR paradigm was first reported in the 1930s. Since then its effects in increasing longevity and delaying the onset of cancer, cardiovascular disease, neurodegenera?on, and diabetes have been firmly established. In the last two decades there has been a large body of work focused on how this simple dietary interven?on can change a process as complicated as aging. Much of the mechanis?c work has been conducted in short-lived species such as worms, flies, and rodents, but the significance for human beings of those insights relies on a demonstra?on that the CR paradigm is relevant in primates. The published work puts that concern to rest. At a more basic level the study shows that the rate of aging can be changed in nonhuman primates indica?ng that it might also be changeable in humans. DNA in humans and rhesus monkeys is 93% iden?cal and there are profound similari?es between humans and rhesus monkeys in the rate of aging, the types of diseases of aging that occur, and how they manifest clinically. This makes it extremely likely that the mechanisms engaged by CR to delay aging in monkeys will be translatable to human health and human aging. The last thing to add is that this study makes a strong case for aging itself as a target for pharmacological interven?on: if the nega?ve outcomes of aging could be delayed by taking a pill, that would poten?ally off-set a whole host of aging associated diseases and disorders simultaneously. This strategy contrasts with classic studies that look for ways to target and treat each age associated disease and disorder one at a ?me.
As for the take-home message, things have never looked be@er in aging research. Using CR as a model of delayed aging it is only a ma@er of ?me before cellular and molecular
